vimarsana.com

Page 15 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WHO approves China s Sinopharm Covid-19 vaccine for emergency use, has 79% efficacy

WHO approves China s Sinopharm Covid-19 vaccine for emergency use, has 79% efficacy WHO approves China s Sinopharm Covid-19 vaccine for emergency use, has 79% efficacy The World Health Organisation has approved China s Sinopharm Covid-19 vaccine for emergency use. The vaccine has an overall efficacy of 79per cent against the disease. advertisement UPDATED: May 8, 2021 02:08 IST Sinopharm (above) is the first Chinese Covid-19 vaccine to get WHO s nod for emergency use. (Photo: AFP) In a big relief for China, the World Health Organisation (WHO) on Friday finally granted the conditional approval to its Sinopharm Covid-19 vaccine for emergency use, a move that could help Beijing step up its vaccine diplomacy amid the surge in coronavirus vaccines in several countries.

WHO Approves Chinese Counter Covid19 Vaccine For Emergency Use

WHO Approves Chinese Counter Covid19 Vaccine For Emergency Use Xinhua reported. The World Health Organization has granted emergency approval for the Covid vaccine made by Chinese firm Sinopharm. It is the first vaccine developed in a non-Western country to get WHO backing. China has already vaccinated millions of people at home and in 45 other countries. “This afternoon, WHO gave emergency use listing to Sinopharm Beijing’s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a press briefing. “This expands the list of vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.